New Orphan Drug Designated
TransMolevular Inc (http://www.transmolecular.com/)
. has been granted orphan drug designation for 131I-TM601,
a Phase 1 clinical treatment for Stage IIb-IV melanoma.
--
John
. has been granted orphan drug designation for 131I-TM601,
a Phase 1 clinical treatment for Stage IIb-IV melanoma.
--
John
posted by siliconsamurai at
5:27 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home